期刊文献+

妊娠糖尿病患者血清高敏C反应蛋白的变化及临床意义 被引量:13

Sensitive C-reactive protein (sC-RP) in gestational diabetes mellitus(GDM)
下载PDF
导出
摘要 在口服糖耐量试验(OGTT)诊断的86例妊娠糖尿病的患者中,高敏C反应蛋白(sCRP)正常61例,升高25例。sCRP升高组的体质指数、OGTT30和60min的胰岛素水平,30和120min的血糖,甘油三酯和心率等,均明显高于sCRP正常组。 The study on GDM with normal sC-RP (1.3±0.9 mmol/L, n=61) and high ~sC-RP (6.3±2.7 mmol/L, n=25) showed that the high sC-RP group had higher levels of BMI, ~OGTT in-sulin at 30, 60 minutes, OGTT plasma glucose at 30 and 120 minutes, TG and heart beating rate as compared with normal sC-RP group.
机构地区 解放军第
出处 《中华糖尿病杂志(1006-6187)》 CSCD 北大核心 2005年第3期170-171,共2页
关键词 妊娠 糖尿病 血清高敏C反应蛋白 OGTT 胰岛素 血糖 Diabetes, gestational C-reactive protein
  • 相关文献

参考文献7

  • 1Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,33:309-315.
  • 2Stern MP. Diabetes and cardiovascular disease:the "common soil" hypothesis. Diabetes,1995,44:369-374.
  • 3吴伟华,张巾超,于江波,刘国良.2型糖尿病及合并大血管病变糖尿病患者C反应蛋白水平观察[J].中华内分泌代谢杂志,2003,19(4):257-259. 被引量:68
  • 4Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes, 2001,50:2384-2389.
  • 5吴伟华,张巾超,刘国良.C-反应蛋白与2型糖尿病大血管病变的相关性研究[J].中国糖尿病杂志,2003,11(4):247-249. 被引量:30
  • 6Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation, 2001,103:357-362.
  • 7Mc Gavock JM, Mandic S, Vonder Muhll I, et al.Low cardiorespiratory fitness is associated with elevated C-reactive protein levels in women with type 2 diabetes. Diabetes Care, 2004,27:320-325.

二级参考文献9

  • 1[1]Maseri A. Inflammation, atherosclerosis, and ischemic events-exploring the hidden side of the moon. New Engl J Med,1997,336:1014-1016.
  • 2[2]Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,33:309-315.
  • 3[3]Stern MP. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes, 1995,44:369-374.
  • 4[4]Barzilay JI, Abraham Linn, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes, 2001,50:2384-2388.
  • 5Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,33:309-315.
  • 6Stern MP. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes, 1995,44:369-374.
  • 7Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes, 2001,50:2384-2388.
  • 8Verma S, Li SH, Badiwada MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 2002,105:1890-1896.
  • 9Dandona P, Aliada A. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and athelosclerosis. Am J Cardiol, 2002,90:27G-33G.

共引文献95

同被引文献79

引证文献13

二级引证文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部